This inventor holds 1 USPTO granted patent. Top assignee: Orion Corporation. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Antti Viitanen: Innovator in Pharmaceutical Compositions
Introduction
Antti Viitanen is a notable inventor based in Espoo, Finland. He has made significant contributions to the field of pharmaceuticals, particularly in the area of cholesterol-lowering compounds. His work has implications for the treatment and prevention of serious health conditions.
Latest Patents
Antti Viitanen holds 1 patent for his invention titled "E-2-[4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy]ethanol and pharmaceutical compositions thereof." This invention is particularly useful in lowering serum cholesterol levels. It also encompasses pharmaceutical compositions that can be utilized for the prevention and treatment of atherosclerosis.
Career Highlights
Viitanen is associated with Orion Corporation, a prominent company in the pharmaceutical industry. His work at Orion has allowed him to focus on innovative solutions that address critical health issues. His research and inventions contribute to the advancement of medical treatments.
Collaborations
Antti Viitanen has collaborated with notable colleagues, including Marja-Liisa Södervall and Arja Marketta Kalapudas. These collaborations have fostered a productive environment for innovation and development in pharmaceutical research.
Conclusion
Antti Viitanen's contributions to the field of pharmaceuticals, particularly through his patent for cholesterol-lowering compounds, highlight his role as an important inventor. His work continues to impact the medical community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile